Aurora Cannabis' Ticking Time Bomb
It's been a wild ride for Aurora Cannabis (NYSE: ACB) so far this year. Analysts came out of the woodwork to recommend the stock early in 2019.
Aurora delivered sizzling revenue growth quarter after quarter. It brought billionaire investor Nelson Peltz on board to help line up partners from outside the cannabis industry. And Aurora accelerated its push to boost production capacity beyond the levels of all its rivals.
All of this helped fuel a meteoric rise for Aurora, with its stock more than doubling at one point. But then came the downturn, and analysts changed their tune about Aurora. The company over promised and under delivered on its fourth-quarter results.
Source Fool.com


